Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study.

@article{Singh2012NoradrenalineVT,
  title={Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study.},
  author={Virendra Singh and Souvik Ghosh and Baljinder Singh and Pradeep Kumar and Navneet Sharma and Ashish Bhalla and Arun Kumar Sharma and Narendra Singh Choudhary and Yogesh Kumar Chawla and Chander Kanwal Nain},
  journal={Journal of hepatology},
  year={2012},
  volume={56 6},
  pages={1293-8}
}
BACKGROUND & AIMS Various vasoconstrictors are useful in the management of hepatorenal syndrome (HRS). Terlipressin is the drug of choice; however, it is expensive. In this study, we evaluated safety and efficacy of terlipressin and noradrenaline in the treatment of HRS. METHODS Forty-six patients with HRS type 1 were managed with terlipressin (group A, N=23) or noradrenaline (Group B, N=23) with albumin in a randomized controlled trial at a tertiary center. RESULTS HRS reversal could be… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Similar Papers

Loading similar papers…